B 2476

Drug Profile

B 2476

Alternative Names: B 24

Latest Information Update: 15 May 1995

Price : $50

At a glance

  • Originator ASTA Medica [CEASED]
  • Class Anti-ischaemics; Antihypertensives
  • Mechanism of Action Beta 1 adrenergic receptor antagonists; Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hypertension

Most Recent Events

  • 15 May 1995 Discontinued-I for Hypertension in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top